CureVac, the latest experimental coronavirus vaccine, proves just 48 percent effective overall, a disappointing result

by

The vaccine is the third to be based on messenger RNA technology that is part of the Pfizer-BioNTech and Moderna vaccines.

View original article
Contributor: Carolyn Y. Johnson